Skip to Content

Eye Cancer Education Resources

MD Anderson offers a wealth of cancer resources for our patients, their families and caregivers. Find educational documents, information on cancer-related topics, and more in the links below.

Patient Education

Español

Related Departments and Programs

Web Resources

MD Anderson has the latest news and information on cancer treatment, research, prevention and education. Explore additional MD Anderson cancer resources in our library of publications.

Why Choose MD Anderson?

  • Latest eye cancer treatments, including specialized surgical techniques to remove cancer but save the eye, proton therapy, targeted therapies, advanced reconstructive surgery for eyelid and orbital cancer
  • Advanced diagnostic techniques including sentinel lymph node biopsy, ultrasound biomicroscopy, confocal biomicroscopy and optical coherence tomography (OCT)
  • Skilled, highly specialized eye surgeons and reconstructive surgeons who have dedicated many years of their career to exclusively treat cancer
  • We treat more eye cancers than most centers
  • Team approach to treating eye cancers
  • Clinical trials of leading-edge treatments for eye cancer

Eye Cancer Knowledge Center

Treatment at MD Anderson

Cancers of the eye are treated in our:

Find Your MD Anderson Location


Eye Cancer Publications

Conjunctival Melanoma 

Savar A,  Esmaeli B, Ho H, Liu S and Prieto V. Conjunctival melanoma: local–regional control rates, and impact of high-risk histopathologic features. J Cutan Pathol 2011: 38: 18–24. 

Esmaeli B. Regional lymph node assessment for conjunctival melanoma: sentinel lymph node biopsy and positron emission tomography. Br. J. Ophthalmol. 2008;92;443-445

Esmaeli B. Sentinel Lymph Node Mapping for Patients With Cutaneous and Conjunctival Malignant Melanoma. Ophthal Plast Reconstr Surg. 2000 May;16(3):170-2.

Orbital Tumors

Savar A, Trent J, Al-Zubidi N, Huh W, Anderson P, Shinder R, Esmaeli B. Efficacy of Adjuvant and Neoadjuvant Therapies for Adult Orbital Sarcomas. Ophthal Plast Reconstr Surg, Vol. 26, No. 3, 2010.

Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer. 2007 Aug 15;110 (4):809-15.

Ahmad SM, Esmaeli B. Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol. 2007 Sep;18(5):405-13.

Woog JJ, Kim YD, Yeatts RP, Kim S, Esmaeli B, Kikkawa D, Lee HB, Korn BS, Punja K, Habermann TM, Colgan JP, Salomao D, Cameron JD. Natural Killer/T-cell Lymphoma with Ocular and Adnexal Involvement. Ophthalmology. 2006 Jan;113(1):140-7. Epub 2005 Dec 19.

DeMartelaere SL, Roberts D, Burgess MA, Morrison WH, Pisters PW, Sturgis EM, Ho V, Esmaeli B. Neoadjuvant chemotherapy-specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement. Head Neck, 2008 May;30(5):639-46.

Skinner HD, Garden AS, Rosenthal DI, Ang KK, Morrison WH, Esmaeli B, Pinnix CC, Frank SJ. Outcomes of Malignant Tumors of the Lacrimal Apparatus. Cancer. 2011 Jun 15;117(12):2801-10. doi: 10.1002/cncr.25813. Epub 2011 Jan 10.

Esmaeli B, McLaughlin P, Pro B, Samaniego F, Gayed I, Hagemeister F, Romaguera J, Cabanillas F, Neelapu SS, Banay R, Fayad L, Wayne Saville M, Kwak LW. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol. 2009 Apr;20(4):709-14. Epub 2009 Jan 15.

Hatef E, Roberts D, McLaughlin P, Pro B, Esmaeli B. Prevalence and Nature of Systemic Involvement and Stage at Initial Examination in Patients With Orbital and Ocular Adnexal Lymphoma.Arch Ophthalmol. 2007;125(12):1663-1667.

Ho VH, Chevez-Barrios P, Jorgensen JL, Silkiss RZ, Esmaeli B. Receptor expression in orbital inflammatory syndromes and implications for targeted therapy. Tissue Antigens. 2007 Aug;70(2):105-9.

Shinder R, Al-Zubidi N, Esmaeli B. Survey of Orbital Tumors at a Comprehensive Cancer Center in the United States. Head Neck. 2011 May;33(5):610-4. Epub 2010 Sep 7.

Shome D, Esmaeli B. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa. Curr Opin Ophthalmol. 2008 Sep;19(5):414-21.

Gayed I, Eskandari MF, McLaughlin P, Pro B, Diba R, Esmaeli B. Value of Positron Emission Tomography in Staging Ocular Adnexal Lymphomas and Evaluating Their Response to Therapy. Ophthalmic Surg Lasers Imaging. 2007 Jul-Aug;38(4):319-25.

Lacrimal Gland Tumors

Ahmad SM, Esmaeli B, Williams M, Nguyen J, Fay A, Woog J, Selvadurai D, Rootman J, Weis E, Selva D, McNab A, DeAngelis D, Calle A, Lopez A. American Joint Committee on Cancer Classification Predicts Outcome of Patients with Lacrimal Gland Adenoid Cystic Carcinoma. Ophthalmology Volume 116, Issue 6, June 2009, pp. 1210-1215. 

Esmaeli B, Ahmadi MA, Youssef A, Diba R, Amato M, Myers JN, Kies M, El-Naggar A. Outcomes in Patients with Adenoid Cystic Carcinoma of the Lacrimal Gland. Ophthal Plast Reconstr Surg. 2004 Jan;20(1):22-6.

Esmaeli B, Golio D, Kies M, DeMonte F. Surgical Management of Locally Advanced Adenoid Cystic Carcinoma of the Lacrimal Gland. Ophthal Plast Reconstr Surg. 2006 Sep-Oct;22(5):366-70.

Uveal Melanoma

Williams MD, Esmaeli B, Soheili A, Simantov R, Gombos DS, Bedikian AY, Hwu P. GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res. 2010 Jun;20(3):184-90.

Sentinel Lymph Node Biopsy

Esmaeli B. Advances in the Management of Malignant Tumors of the Eyelid and Conjunctiva: The Role of Sentinel Lymph Node Biopsy. Int Ophthalmol Clin. 2002 Spring;42(2):151-62.

Savar A, Ross MI, Prieto VG, Ivan D, Kim SK, Esmaeli B. Sentinel Lymph Node Biopsy for Ocular Adnexal Melanoma: Experience in 30 Patients. Ophthalmology 116 (11):2217-23, 2009.


© 2014 The University of Texas MD Anderson Cancer Center